FDA 483 OBSERVATION · #214 OF 1,945 MOST-CITED
Determination based on screening and testing
FDA cited this observation 140 times across 120 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 2.1× the rate of the average FDA-cited firm (16.7% vs 7.8%), across 120 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
HCT/P donors were not determined to be eligible based on the results of donor screening and testing.
HCT/P donors were not determined to be eligible based on the results of donor screening and testing.
HCT/P donors were not determined to be eligible based on the results of donor screening and testing.
HCT/P donors were not determined to be eligible based on the results of donor screening and testing.
HCT/P donors were not determined to be eligible based on the results of donor screening and testing.
HCT/P donors were not determined to be eligible based on the results of donor screening and testing.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →